Physician profile
Robert Allen
NPI 1578533584
$1,258.44
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $493 · 2021: $252 · 2022: $249.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $371.74 | 2020-2022 | |
| Astrazeneca Pharmaceuticals Lp | $149.46 | 2019-2020 | |
| Lilly USA, LLC | $98.34 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.39 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $67.08 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $65.14 | 2019-2022 | |
| Amgen INC. | $53.60 | 2019-2020 | |
| Pfizer INC. | $44.83 | 2019-2022 | |
| Abbvie INC. | $44.69 | 2021 | |
| Janssen Pharmaceuticals, INC | $42.92 | 2019 | |
| Allergan, INC. | $42.87 | 2020 | |
| Global Blood Therapeutics, INC. | $41.99 | 2020-2021 | |
| Astellas Pharma US INC | $23.39 | 2019 | |
| Glaxosmithkline, LLC. | $22.85 | 2022 | |
| Atricure, INC. | $22.27 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.50 | 2022 | |
| Amarin Pharma, INC. | $17.80 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.35 | 2019 | |
| Corcept Therapeutics | $13.25 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.24 | 2021 | |
| Medtronic Vascular, INC. | $11.74 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.